Delivery Order SPE2DR25D2014-SPE2DR26FZ83F
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Nucynta (tapentadol) 100 mg tablets in a quantity of 100 units under a firm fixed-price contract. The order, issued on October 22, 2025, carries a ceiling value of $4,550.07 with an ultimate completion date of October 23, 2025. This non-competitive delivery order represents a routine pharmaceutical procurement supporting military and federal healthcare needs. The place of performance is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for supply of Nucynta (tapentadol) 100 mg tablets in a quantity of 100 units, with a contract value of $1,908.20. This competitive award, issued on October 22, 2025, with an ultimate completion date of October 23, 2025, utilizes firm fixed pricing and carries no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, performs this...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 2, 2025, for the supply of Nucynta (tapentadol) 50 mg tablets in a quantity of 100 units, with a contract ceiling value of $4,413.94. This delivery order represents a firm fixed price, non-set-aside contract with a completion date of December 3, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award is issued as a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Nucynta (tapentadol) 50 mg tablets in quantities of 100, valued at $2,251.72. This firm fixed-price delivery order is not set-aside and will be completed by November 5, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement supporting federal medical supply needs,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Nucynta (tapentadol) 100 mg tablets in quantities of 100 units. This is a firm fixed-price delivery order valued at $12,347.38 with an ultimate completion date of October 28, 2025. The contract was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $3,457.97 to AmerisourceBergen Drug Corp for the supply of Nucynta (tapentadol) 100 mg tablets in quantities of 100 units. This firm fixed-price, competitively awarded delivery order was executed on October 22, 2025, with an ultimate completion date of October 23, 2025. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania served as the place of performance for this pharmaceutical procurement. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $6,084.20 to AmerisourceBergen Drug Corp for the supply of Nucynta (tapentadol) 50 mg tablets in quantities of 100 units. The contract, established under a firm fixed-price delivery order structure, was competitively awarded without set-aside provisions and is scheduled for completion by August 25, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this...
- The Defense Logistics Agency awarded a $1,386.74 delivery order to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of Nucynta (tapentadol) 75 mg tablets in quantities of 100 units. This is a firm fixed price delivery order with an ultimate completion date of December 2, 2025, and represents a non-competitive award. The contract will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $2,450.08 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 100 tablets of Nucynta (tapentadol) 50 mg, with a completion date of June 16, 2025. This non-set-aside competitive award was issued to AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania, the company's headquarters. The delivery order represents a single transaction under AmerisourceBergen's broader pharmaceutical supply framework with the federal government....
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,253.88 to AmerisourceBergen Drug Corp for the supply of Nucynta (tapentadol) 50 mg tablets in quantities of 100 units. This competitive delivery order, which was not set-aside for any socioeconomic category, was awarded on July 14, 2025, with an ultimate completion date of July 15, 2025, under firm fixed-price terms. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania,...
- SPE2DR25D2014Indefinite Delivery Contract
- SPE2DR25D2014-SPE2DR26FZ83FDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Nucynta (tapentadol) 50 mg tablets in a quantity of 100 units, valued at $1,186.00. This firm fixed-price delivery order, issued on December 1, 2025, with completion targeted for December 2, 2025, represents a non-competitive, non-set-aside award to the pharmaceutical distributor's Conshohocken, Pennsylvania facility. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion global pharmaceutical support vehicle running through December 2026 that authorizes the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, maintains a significant federal contract portfolio with DLA focused on delivering medications across multiple therapeutic domains to support Defense Health Agency and military healthcare systems. As a child delivery order under the broader SPE2DX IDC, this award demonstrates the company's continued role as a critical vendor in the federal medical supply chain, fulfilling routine pharmaceutical procurement needs for defense medical operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 11/30/25 |